MYELOSUPPRESSION AND MONITORING OF ABSOLUTE NEUTROPHIL COUNTS IN EPIRUBICIN/CYCLOPHOSPHAMIDE-TREATED BREAST CANCER PATIENTS: RESULTS FROM A PHASE-2A COLLABORATIVE TRIAL OF THE AGO-B AND CESAR STUDY GROUPS
Authors:
- Dirk PleimesDPDirk Pleimes
- Corinna AsangCACorinna Asang
- Frank MayerFMFrank Mayer
- Frauke FriedrichsFFFrauke Friedrichs
- 14 June 2019
- conference paper
- Published by Morressier GmbH